الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 102 |  |  |
| | | from | 102 | | |
Abstract
CRS is a chronic disease that characterized by inflammation of the mucosa of the nose and paranasal sinuses of at least 12 consecutive weeks duration.
Current treatment options for patients with CRS range from medical therapy in the form of antibiotics, antihistamines, corticosteroids to surgical intervention in the form of FESS.
In 2005, Balloon sinuplasty technology was approved for use in the United States by Food and Drug Administration (FDA) as a minimally invasive treatment alternative for the chronic rhinosinusitis. Balloon Sinuplasty alters the sinus cavities by reshaping the bony structure, as opposed to FESS where bone is actually removed, with minimal mucosal damage, minimal intraoperative bleeding and minimal discomfort.
The procedure can be performed under local anesthesia or conscious sedation, so it holds promises for office type sinus procedures. The balloon sinuplasty appears to be a feasible, safe and effective procedure in selected patients. It presents itself as complementary to functional endoscopic sinus surgery used in the treatment of chronic rhinosinusitis patients who have failed antibiotic therapy, topical steroids and anti-allergic management as demonstrated by an abnormal CT scan.
In theory, balloons may be best used in early disease states, before significant mucosal and bony osteitis has occurred. It has greater prospects in the treatment of the disease related to the frontal recess. It also has an excellent prespective in ICU febrile patient with sinusal focus and patients with high anesthetic and bleeding risks. Sinuplasty morbidity and complications are the same as with FESS; however, owing to the less invasive nature of the procedure, they are likely to be less common.
Although limited to the frontal, maxillary and sphenoid sinuses, the technique of the procedure is achievable with appropriate training, minimal morbidity and complications. However, its long-term value as a stand-alone procedure has not yet been proven.